These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19041697)

  • 1. Effects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells.
    Zang Y; Odwin-Dacosta S; Yager JD
    Toxicol Lett; 2009 Jan; 184(2):134-8. PubMed ID: 19041697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells.
    Huff MO; Todd SL; Smith AL; Elpers JT; Smith AP; Murphy RD; Bleser-Shartzer AS; Hoerter JE; Radde BN; Klinge CM
    Toxicol Sci; 2016 Jul; 152(1):62-71. PubMed ID: 27071941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
    Song X; Wei Z; Shaikh ZA
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidences for involvement of estrogen receptor induced ERK1/2 activation in ovarian cancer cell proliferation by Cadmium Chloride.
    Ataei N; Aghaei M; Panjehpour M
    Toxicol In Vitro; 2019 Apr; 56():184-193. PubMed ID: 30682495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
    Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.
    Reddy KB; Yee D; Hilsenbeck SG; Coffey RJ; Osborne CK
    Cell Growth Differ; 1994 Dec; 5(12):1275-82. PubMed ID: 7696176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
    Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
    J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
    Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
    Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
    Nakareangrit W; Thiantanawat A; Visitnonthachai D; Watcharasit P; Satayavivad J
    Environ Toxicol; 2016 Sep; 31(9):1133-46. PubMed ID: 25728338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
    Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
    Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.
    Niwa T; Takanobu J; Suzuki K; Sato Y; Yamaguchi Y; Hayashi SI
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105671. PubMed ID: 32289430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium.
    Liu Z; Yu X; Shaikh ZA
    Toxicol Appl Pharmacol; 2008 May; 228(3):286-94. PubMed ID: 18275979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
    Lu Y; Jiang S; Zhang J; Song H; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA.
    Pentecost BT; Bradley LM; Gierthy JF; Ding Y; Fasco MJ
    Mol Cell Endocrinol; 2005 Jun; 238(1-2):9-25. PubMed ID: 15913882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.
    Zimmermann M; Arachchige-Don AP; Donaldson MS; Patriarchi T; Horne MC
    Cell Cycle; 2016 Dec; 15(23):3278-3295. PubMed ID: 27753529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
    Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
    Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors.
    Harnagea-Theophilus E; Gadd SL; Knight-Trent AH; DeGeorge GL; Miller MR
    Toxicol Appl Pharmacol; 1999 Mar; 155(3):273-9. PubMed ID: 10079213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.